CSIMarket
 


Radnet, Inc.  (RDNT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

RDNT's Income from Cont. Operations Growth by Quarter and Year

Radnet,'s Income from Cont. Operations results by quarter and year




RDNT Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 5.77 3.85 1.99
III Quarter September 5.09 6.47 5.62 3.38
II Quarter June 7.59 -5.45 -0.86 -1.43
I Quarter March 31.35 -6.54 4.06 1.26
FY   44.03 0.25 12.67 5.20



RDNT Income from Cont. Operations third quarter 2019 Y/Y Growth Comment
Radnet, Inc. reported decline in Income from Cont. Operations in the third quarter by -21.3% to $ 5.09 millions, from the same quarter in 2018.
The contraction in the third quarter Radnet, Inc.'s Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations doubling of 976.43%.

Looking into third quarter results within Medical Laboratories industry 11 other companies have achieved higher Income from Cont. Operations growth. While Radnet, Inc.' s Income from Cont. Operations fall of -21.3% ranks overall at the positon no. 1200 in the third quarter.




RDNT Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 49.87 % 93.47 % -76 %
III Quarter September -21.3 % 15.12 % 66.27 % -5.06 %
II Quarter June - - - -
I Quarter March - - 222.22 % -70.7 %
FY   - -98.03 % 143.65 % -

Financial Statements
Radnet,'s third quarter 2019 Income from Cont. Operations $ 5.09 millions RDNT's Income Statement
Radnet,'s third quarter 2018 Income from Cont. Operations $ 6.47 millions Quarterly RDNT's Income Statement
New: More RDNT's historic Income from Cont. Operations Growth >>


RDNT Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -10.82 % -31.49 % -41.12 %
III Quarter September -32.91 % - - -
II Quarter June -75.79 % - - -
I Quarter March 443.33 % - 104.02 % -84.8 %
FY (Year on Year)   - -98.03 % 143.65 % -




Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #83
Overall #1200

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
15214.46 % 976.43 % -95.87 %
(Dec 31 2018)   (Dec. 30, 2013)
Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #83
Overall #1200
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
15214.46 % 976.43 % -95.87 %
(Dec 31 2018)   (Dec. 30, 2013)

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Radnet,'s Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
1035.49 % 130.59 % -84.8 %
(Dec 31 2012)  


RDNT's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2019 Radnet, Inc. reported fall in Income from Cont. Operations from the second quarter by -32.91% to $ 5.09 millions, from $ 7.59 millions declared in the previous reporting period.

Within Medical Laboratories industry 14 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Radnet,'s Income from Cont. Operations growth quarter on quarter, overall rank is 1438.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #95
Overall #1438
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #95
Overall #1438
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
1035.49 % 130.59 % -84.8 %
(Dec 31 2012)  


RDNT's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2019 Radnet, Inc. reported fall in Income from Cont. Operations sequentially by -32.91% to $ 5.09 millions, from $ 7.59 millions released in the previous qaurter.

Within Medical Laboratories industry 14 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Radnet,'s Income from Cont. Operations growth quarter on quarter, overall rank is 1438.


Radnet,'s 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Income from Cont. Operations 12 Months Ending $ 49.80 $ 51.18 $ 38.13 $ 0.25 $ -1.68
Y / Y Income from Cont. Operations Growth (TTM) - - 1737.73 % -98.04 % -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # 31 # 2220
Seqeuential Income from Cont. Operations Change (TTM) -2.69 % 34.21 % 15214.46 % - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1200 # 189 # 5 # 0 # 0




Cumulative Income from Cont. Operations growth Comment
In the Sep 30 2019 period, Radnet, had cumulative twelve months Income from Cont. Operations of $ 50 millions compare to loss from continued operations of $ -2 millions a year ago.

Radnet, Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
15214.46 %
976.43 %
-95.87 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall # 0

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1737.73 %
151.46 %
-98.04 %
(Dec 31 2018)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 83
S&P 500 # 1200
Cumulative Income from Cont. Operations growth Comment
In the Sep 30 2019 period, Radnet, had cumulative twelve months Income from Cont. Operations of $ 50 millions compare to loss from continued operations of $ -2 millions a year ago.

Radnet, Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
15214.46 %
976.43 %
-95.87 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall # 0

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1737.73 %
151.46 %
-98.04 %
(Dec 31 2018)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 83
S&P 500 # 1200




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
RDNT's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for RDNT's Competitors
Income from Cont. Operations Growth for Radnet,'s Suppliers
Income from Cont. Operations Growth for RDNT's Customers

You may also want to know
RDNT's Annual Growth Rates RDNT's Profitability Ratios RDNT's Asset Turnover Ratio RDNT's Dividend Growth
RDNT's Roe RDNT's Valuation Ratios RDNT's Financial Strength Ratios RDNT's Dividend Payout Ratio
RDNT's Roa RDNT's Inventory Turnover Ratio RDNT's Growth Rates RDNT's Dividend Comparisons



Companies with similar Income from Cont. Operations fall for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2019
Quest Diagnostics Inc -0.44 %$ -0.441 millions
Dexcom, Inc. -1.72 %$ -1.717 millions
Merck & Co., Inc. -2.60 %$ -2.605 millions
Procyon Corp -3.94 %$ -3.941 millions
Innoviva, inc. -6.21 %$ -6.211 millions
Radnet, Inc. -11.80 %$ -11.796 millions
Masimo Corp -14.08 %$ -14.076 millions
Hca Healthcare, Inc. -14.73 %$ -14.732 millions
Bio-techne Corp -17.27 %$ -17.267 millions
Pro Dex Inc -18.16 %$ -18.162 millions
Stryker Corp -21.02 %$ -21.017 millions
Zynex Inc -21.54 %$ -21.536 millions
Magellan Health, inc. -21.63 %$ -21.628 millions
Ani Pharmaceuticals Inc -22.67 %$ -22.672 millions
Exelixis, Inc. -23.04 %$ -23.042 millions
Bristol Myers Squibb Co -28.56 %$ -28.556 millions
Healthcare Services Group Inc -29.68 %$ -29.679 millions
Laboratory Corp Of America Holdings -30.72 %$ -30.721 millions
Nuvasive Inc -30.85 %$ -30.855 millions
Jazz Pharmaceuticals Plc -31.50 %$ -31.504 millions
Standard Diversified Inc. -36.36 %$ -36.364 millions
Petmed Express Inc -38.01 %$ -38.012 millions
Techcare Corp. -38.18 %$ -38.184 millions
Amphastar Pharmaceuticals, Inc. -39.11 %$ -39.109 millions
Universal Health Services Inc -42.32 %$ -42.321 millions
Tivity Health, Inc. -45.10 %$ -45.104 millions
Utah Medical Products Inc -45.21 %$ -45.209 millions
Jrsis Health Care Corp -46.24 %$ -46.238 millions
Psychemedics Corp -46.90 %$ -46.902 millions
Biotelemetry, Inc. -48.23 %$ -48.234 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VMC's Profile

Stock Price

VMC's Financials

Business Description

Fundamentals

Charts & Quotes

VMC's News

Suppliers

VMC's Competitors

Customers & Markets

Economic Indicators

VMC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071